LLY

992.1

+1.45%↑

JNJ

243.48

-0.21%↓

ABBV

224.42

-1.08%↓

NVS

153.89

-0.26%↓

AZN

190.23

-0.59%↓

LLY

992.1

+1.45%↑

JNJ

243.48

-0.21%↓

ABBV

224.42

-1.08%↓

NVS

153.89

-0.26%↓

AZN

190.23

-0.59%↓

LLY

992.1

+1.45%↑

JNJ

243.48

-0.21%↓

ABBV

224.42

-1.08%↓

NVS

153.89

-0.26%↓

AZN

190.23

-0.59%↓

LLY

992.1

+1.45%↑

JNJ

243.48

-0.21%↓

ABBV

224.42

-1.08%↓

NVS

153.89

-0.26%↓

AZN

190.23

-0.59%↓

LLY

992.1

+1.45%↑

JNJ

243.48

-0.21%↓

ABBV

224.42

-1.08%↓

NVS

153.89

-0.26%↓

AZN

190.23

-0.59%↓

Home・Aandelen Lijst・Vivani Medical

Vivani Medical

Open

1.09 -0.91

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1.09

Max

1.12

Belangrijke statistieken
By Trading Economics
Inkomsten	614K -6.5M
Werknemers	37

Dividenden
By Dow Jones
Volgende Winsten	30 mrt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-25M 79M
Vorige openingsprijs	2
Vorige sluitingsprijs	1.09

Vivani Medical Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

12 mrt 2026, 23:12 UTC

Populaire aandelen

Stocks to Watch: Adobe, Mission Produce, Buzzfeed, Ulta

12 mrt 2026, 22:15 UTC

Winsten

Wheaton Precious Metals Logs Higher 4Q Net Income, Boosts Dividend 18%

12 mrt 2026, 21:42 UTC

Belangrijke Nieuwsgebeurtenissen

Stryker Says Cyberattack Disruption Is Continuing

12 mrt 2026, 21:29 UTC

Belangrijke Nieuwsgebeurtenissen

Correction to War in Iran May Upend Brazil Central Bank's Plans Article

12 mrt 2026, 21:27 UTC

Winsten

Adobe CEO to Depart as AI Boosts Sales -- Update

12 mrt 2026, 20:46 UTC

Winsten

Adobe Posts Higher Sales With CEO Set to Depart

12 mrt 2026, 20:21 UTC

Belangrijke Nieuwsgebeurtenissen

Soybean Futures Higher on Instability in Iran --Daily Grain Highlights

12 mrt 2026, 23:57 UTC

Marktinformatie

Gold Edges Higher Amid Ongoing Middle East Conflict -- Market Talk

12 mrt 2026, 23:38 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

12 mrt 2026, 23:38 UTC

Marktinformatie

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

12 mrt 2026, 22:13 UTC

Winsten

Orient Overseas: Tariff Measures, Trade Tensions Weighed on Results >0316.HK

12 mrt 2026, 22:13 UTC

Winsten

Orient Overseas: Middle East Situation Have Added to Future Uncertainity >0316.HK

12 mrt 2026, 22:13 UTC

Winsten

Orient Overseas: Charter Market Remains Exceptionally Tight With Vessels in Short Supply >0316.HK

12 mrt 2026, 22:13 UTC

Winsten

Orient Overseas 2025 Rev $9.72B Vs. $10.70B >0316.HK

12 mrt 2026, 22:13 UTC

Winsten

Orient Overseas 2025 Net $1.51B Vs. Net $2.58 >0316.HK

12 mrt 2026, 22:13 UTC

Marktinformatie

Winsten

Global Equities Roundup: Market Talk

12 mrt 2026, 22:13 UTC

Marktinformatie

Winsten

Adobe Says Customers Want to Try AI Products for Free First -- Market Talk

12 mrt 2026, 21:16 UTC

Acquisities, Fusies, Overnames

Alexander & Baldwin: JV Formed by Affil of MW Group and Funds Affiliated With Blackstone and DivcoWest Completed Acquisition of All Outstanding A&B Common Shrs >ALEX

12 mrt 2026, 21:04 UTC

Winsten

Adobe Earnings Beat Is Overshadowed by CEO Departure. The Stock Is Sliding. -- Barrons.com

12 mrt 2026, 21:02 UTC

Winsten

Wheaton Precious Metals 4Q Adj EPS $1.22 >WPM

12 mrt 2026, 21:02 UTC

Winsten

Wheaton Precious Metals 4Q Sales $865M >WPM

12 mrt 2026, 21:02 UTC

Winsten

Wheaton Precious Metals 4Q Net $558.3M >WPM

12 mrt 2026, 21:02 UTC

Winsten

Wheaton Precious Metals 4Q EPS $1.23 >WPM

12 mrt 2026, 20:57 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

No Need For Canada Rate Increases Amid Jump in Bond Yields -- Market Talk

12 mrt 2026, 20:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

12 mrt 2026, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

12 mrt 2026, 20:15 UTC

Acquisities, Fusies, Overnames

Eaton Completes Acquisition Of Leading Liquid-cooling Solutions Provider Boyd Thermal, Creating An Industry-leading Grid-to-chip Solution For Data Centers >ETN

12 mrt 2026, 20:10 UTC

Winsten

Adobe Sees 2Q Rev $6.43B-$6.48B >ADBE

12 mrt 2026, 20:05 UTC

Winsten

Adobe 1Q Rev $6.4B >ADBE

12 mrt 2026, 20:05 UTC

Winsten

Adobe Sees 2Q Adj EPS $5.80-Adj EPS $5.85 >ADBE

Peer Vergelijking

Prijswijziging

Vivani Medical Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

Buy

Hold

Sell

Gebaseerd op 0 analisten die aandelenratings hebben gegeven aan Vivani Medical - Dist in de afgelopen 3 maanden.

Financieel

Verkoop- en administratiekosten

Winst voor belastingen

Verkoop

Operationele winst

Over Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.